In a similar fashion, the SNP rs863826 A/A genotype was associated with DHT-induced downregulation of TMEM9 (Fig. 4f) and with reduced risk of relapse in the MA27 BC cohort who received AI therapy (Fig. 4l). Here, TMEM9 is linked to breast cancer.